SPY
770.73
+0.22%
QQQ
722.85
+0.73%
BTC/USD
83,122.07
+0.22%
DIA
524.31
−0.01%
GLD
377.24
−0.11%
TLT
79.93
−0.25%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Stock Trading Ideas
Elon Musk Confirms SpaceX, Tesla Merger Committees, Calls Deal ‘A Good Idea’
SpaceX Is Launching More Than Satellites: The Next Frontier Is Space Cybersecurity
Capital One Stock Climbs After Q3 Earnings Blow Past Estimates
SpaceX Is Launching More Than Satellites: The Next Frontier Is Space Cybersecurity
Capital One Stock Climbs After Q3 Earnings Blow Past Estimates
SpaceX Delivers Q3 Double Beat as AI Revenue Soars
United Airlines Stock Sinks After Q3 Results Miss Estimates
SpaceX Delivers Q3 Double Beat as AI Revenue Soars
United Airlines Stock Sinks After Q3 Results Miss Estimates
GM Bets on Super Cruise to Drive Software Growth. The $7.5B Story Is Bigger
GE Aerospace Turns To AI To Ease Engine Maintenance Bottlenecks
Read More...
Trading Ideas Recent News
Space Stocks Coast Through SpaceX Q3 Print: Rocket Lab, Firefly Steady
SpaceX beat Q3 revenue and earnings estimates, fueled by surging AI and Starlink growth, while space-sector peers saw muted gains.
Here’s How Much $100 Invested in Tesla Stock Today Could be Worth if Cathie Wood’s Prediction Comes True in 2031
Cathie Wood has a new price target for Tesla stock. Here's what that means if you buy shares today.
Netflix Q3 Highlights: Shares Slide As Earnings Beat Overshadowed by Weak Q4 Guidance
Netflix shares are falling after Q3 results. Here's why.
Bloom Energy Stock Slides: What's Going On?
Bloom Energy shares are drifting lower Tuesday. Traders position ahead of the fuel cell maker’s Q3 results due Thursday after the close.
Airline Stocks Move Higher as Oil Prices Fall
Airline stocks are climbing Tuesday as crude oil slips, while investors brace for United Airlines’ third quarter report after the close.
Why Is Bitmine Stock Surging on Tuesday?
Bitmine Immersion Technologies (NYSE:BMNR) stock is surging Tuesday as digital assets bounce. Read details on its Ethereum treasury and Tom Lee’s market outlook.
SpaceX Prepares for Q3 Earnings with Focus on Starship, AI Spending
SpaceX stock trades near flat ahead of Q3 earnings as analysts weigh $100B revenue run-rate targets, Starlink mobile expansion and AI infrastructure capex.
Meta Q3 Preview: Muse Put Company in Spotlight, Will Financials Support a Rally?
Meta can monetize AI, analysts say. Opportunities could be on full display in Q3 results. Here are the key items to watch.
QUICK SPARK: GTA VI Launch Could Cost US Economy $1B in a Day
GTA VI may trigger 1.5 million U.S. absences and $1B in lost productivity, while boosting Take-Two amid strong preorders.
Meta Heads Into Earnings With AI Ambitions Soaring, Cash Burn in Focus
Wall Street stays bullish on Meta (META) ahead of Q3 earnings. Strong AI ad growth and Muse agent potential drive $880+ price targets.
Revolution Medicines Begins Phase 3 Trial For Advanced Lung Cancer Treatment
Revolution Medicines doses first patients in its global Phase 3 trial testing zoldonrasib for metastatic non-small cell lung cancer.
Mitsubishi Heavy Industries’ Investment Case—2026 Earnings Set the Stage
Mitsubishi Heavy Industries Ltd. (OTC:MHVIY) is attracting attention as Japan increases its focus on defense capabilities, energy security and industrial resilience. Unlike companies tied to a single technology or end
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study
AstraZeneca and Amgen report positive Phase 3 Tezspire data, showing sustained remission in eosinophilic esophagitis patients over 52 weeks.
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Don't Miss Your Free Daily Briefing!
Subscribe to Benzinga’s free daily market updates and get all the major investing news and best stock picks in your inbox every morning!
Every Story That Matters Around The Web
SpaceX Delivers Q3 Double Beat as AI Revenue Soars - SpaceX (NASDAQ:SPCX) - Benzinga
Wife, 47, ‘Completely Blindsided’ After Husband, 65, Says Daughter Will Inherit Their Home. ‘I Deserve to Be Compensated’
SpaceX Q3 2026 Earnings Call Transcript - SpaceX (NASDAQ:SPCX) - Benzinga
'Are You Giving Taxpayers Shares?' — Tucker Carlson Grills Kevin O'Leary Over $15 Billion Utah Data Center Asking Taxpayers To Pay
When Did It Become ‘Normal’ For Gen X To Be Responsible For 3 Generations? — Mom Caring For Teens And Parents Says 'Women Are Not Uniquely Built'
Iran Foreign Minister Says Emmanuel Macron ‘Made His Bed’ With Trump Over Iran War as Curfew Imposed in Parts of Paris: ‘Listen to the Future of France’